CLA

CLA reduces weight gain, increases lean muscle mass, reduces the amount of body fat and maintains body weight level.

CLA company has been given clearance by the FDA to use four health claims on its Clarinol CLA product.

In June, the company, Lipid Nutrition submitted a voluntary notification to the FDA, and can now officially claim that Clarinol CLA reduces weight gain, increases lean muscle mass, reduces the amount of body fat and maintains body weight level.

“The passage of 30 days after filing the structure/function claims means that the FDA believes we have substantial evidence to make such claims,” said David Lewis, the business unit manager, North America, for Lipid Nutrition. “With this notification we expect to expand the marekting ativities of Clarinol CLA.” This development follows the introduction of Clarinol A95, which is said to offer the highest form of active CLA isomers at 95 percent. Lipid Nutrition claims that Clarinol A95 offers distinct advantages over the conventional 80 percent active CLA concentration by allowing for a more highly concentrated 1-gram capsule, thereby enabling nutraceutical manufacturers to offer a smaller capsule to the consumer.

Back in March, Lipid Nutrition became the first company to demonstrate the safety of its conjugated linoleic acid, announcing that a panel of independent experts had declared that Clarinol CLA could be ‘generally recognized as safe’, giving it the self-affirmed ‘GRAS’ status required before US food manufacturers begin using an ingredient.

Among the data provided to the panel, Lipid Nutrition submitted results of a safety study on 60 people who took 7.5 grams of Clarinol for one year, without side effects.

CLA Weight Loss